Feds Accept Plan To Mitigate Suicide Risk At Western State Hospital
Washington state’s largest psychiatric hospital is no longer in immediate jeopardy of losing federal funding.
Last week, federal inspectors found serious safety violations at Western State Hospital that could put patients at risk of suicide. They spent several days at Western State looking for full compliance with federal standards. Now the Centers for Medicare and Medicaid Services has accepted the hospital’s immediate plan to address the suicide risk issues.
The hospital has been in a sort of turnaround mode for the last two years. A number of problems leading up to 2016 emerged at the hospital ranging from management failures to significant safety issues that imperiled the health and safety not just of the patients, but the staff at this hospital.
This most recent inspection is widely viewed as the hospital’s last chance to meet federal standards. Final survey results are expected at the end of June. At stake is $65 million in federal funding each year that goes to help run this hospital.
No figures on wildland firefighter suicides are available because federal agencies often track only fatalities that occur during work hours, and families don’t always release a cause of death. But lang management agencies are concerned about an increasing number of suicides, and seeking to address ways to help. Continue Reading Federal Agencies Boost Efforts To Address Wildland Firefighter Suicides
Seattle is grappling with a crisis of what is sometimes called “visible homelessness” — people who live in the street and struggle with mental illness or drug addiction. It’s a population that often commits small crimes, such as disorderly conduct or shoplifting to pay for drugs. And public frustration is growing. Continue Reading Seattle Faces Backlash After Easing Up On Punishing Crimes Involving Mental Illness
Researchers are using brain scans, blood and spinal fluid to detect early signs of Alzheimer’s disease. These “biomarkers” may also offer a quicker way to test new Alzheimer’s drugs. Continue Reading New Markers For Alzheimer’s Disease Could Aid Diagnosis And Speed Up Drug Development